After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 34.56% to $13.20 in after-hours trading.
After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 34.56% to $13.20 in after-hours trading.
Copyright © Louis Velazquez. All Rights Reserved.